| Primary |
| Product Used For Unknown Indication |
100.0% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
29.2% |
| Product Used For Unknown Indication |
18.5% |
| Helicobacter Infection |
9.2% |
| Herpes Zoster |
9.2% |
| Back Pain |
6.2% |
| Diabetes Mellitus Non-insulin-dependent |
6.2% |
| Diabetes Mellitus |
4.6% |
| Neuralgia |
4.6% |
| Hypertension |
3.1% |
| Analgesic Therapy |
1.5% |
| Antiinflammatory Therapy |
1.5% |
| Antipyresis |
1.5% |
| Bacterial Infection |
1.5% |
| Influenza |
1.5% |
| Rheumatoid Arthritis |
1.5% |
|
| Renal Failure Acute |
9.1% |
| Shock |
9.1% |
| Suicide Attempt |
9.1% |
| Transaminases Increased |
9.1% |
| Vasculitis |
9.1% |
| Vomiting |
9.1% |
| Anxiety |
4.5% |
| Gastric Ulcer |
4.5% |
| Hepatic Enzyme Increased |
4.5% |
| Hypoaesthesia |
4.5% |
| Hypokalaemia |
4.5% |
| Mixed Liver Injury |
4.5% |
| Nausea |
4.5% |
| No Adverse Event |
4.5% |
| Peripheral Coldness |
4.5% |
| Urosepsis |
4.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.0% |
| Product Used For Unknown Indication |
22.6% |
| Rheumatoid Arthritis |
9.7% |
| Pain |
8.8% |
| Hypertension |
4.4% |
| Diabetes Mellitus |
3.0% |
| Prophylaxis |
2.6% |
| Headache |
2.1% |
| Depression |
1.8% |
| Neuralgia |
1.7% |
| Psoriatic Arthropathy |
1.7% |
| Ankylosing Spondylitis |
1.7% |
| Renal Failure Chronic |
1.5% |
| Constipation |
1.4% |
| Infection |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Essential Hypertension |
1.4% |
| Multiple Myeloma |
1.3% |
| Arthralgia |
1.2% |
| Analgesic Therapy |
1.1% |
|
| Vomiting |
11.3% |
| Osteonecrosis |
10.7% |
| Pyrexia |
9.6% |
| Cerebral Infarction |
5.6% |
| Vision Blurred |
5.1% |
| Weight Decreased |
5.1% |
| Weight Increased |
5.1% |
| Pneumonia |
4.5% |
| Pulmonary Embolism |
4.5% |
| Renal Failure Acute |
4.5% |
| Hypotension |
4.0% |
| Rash |
4.0% |
| Atrial Fibrillation |
3.4% |
| Pancreatitis |
3.4% |
| Sensory Disturbance |
3.4% |
| Sepsis |
3.4% |
| Syncope |
3.4% |
| Thrombocytopenia |
3.4% |
| Hypoglycaemia |
2.8% |
| Nausea |
2.8% |
|
